Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal Tumors
Clinical trial NCT04258462 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04258462
- Sponsor
- Zhen Wang, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-15
- Primary completion
- 2026-10-31
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.